A homegrown vaccine
New Zealand needs the capacity to develop and manufacture our own vaccines.
Planning in covid-19 is complex because humans have never had this particular virus before, says Sir Peter Gluckman.
The illusion of privacy has been shattered. Journalists exposing the truth of our smartphones.
Ransomware is a term that’s been firmly in the news this year with several high-profile attacks hitting the headlines.
The best single predictor of vaccine uptake per US state is the share of the population that believes the human race has always existed.
New Zealand’s new stock market for SMEs, Catalist, could boost growth among businesses that are too small for the NZX.
Sorry, nothing was found. Please try a different set of filters.
Building your professional body for the future | The top 5 issues directors face in 2020 | IoD Rules review | D&O insurance
Will we ever be post-COVID? | Ko wai a TAHITO | Lessons learned | Challenges facing CEOs | Renovation time
The board's role in a crisis | The challenge of assisted dying | Political visions
How is climate action unfolding in NZ? We ask how boards are balancing short-term financial pressures with long-term sustainability goals.